Research Projects

By implementing and participating in different research projects, we support the research of ABCB5+ stem cells in order to be able to offer new fields of application and new chances to our clients.

 

Current Research Projects

TICEBA BlueMan Forschung

Limbal stem cell deficiency

Solid tumors

Cirrhosis of the liver

Kidney Regeneration

Epdermolysis Bullosa

Peripheral arterial occlusive disease

Chronic venous ulcer - autologous and allogeneic

Diabetic foot ulcer

Closed Researched Projects

 

TICEBA - Clinical Studies - Clinical Phase

News
Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcer (CVU), diabetic foot ulcer (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.

License

Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.

Newsletter